This study aims to understand Alzheimer's Disease (AD) by using special tests called biomarkers. Biomarkers help doctors see changes in the brain and body that might show AD. The study, called ADNI4, will last up to 5 years and will involve 1,150 participants aged 55-90 from the US and Canada. Participants can be healthy, have mild memory problems, or have dementia.
In this study, participants will have various tests, including memory and thinking tests, brain scans like MRI (Magnetic Resonance Imaging) and PET (Positron Emission Tomography), and tests on blood and spinal fluid. Some participants are new, while others have been in past ADNI studies.
- Participants will have tests and scans regularly for up to 5 years.
- No new treatments will be tested; it's a natural observation study.
- Eligible participants must be willing to have various tests and not have certain medical conditions.
To qualify, you need to be in good health, have a study partner, and be able to visit study sites. For more information, visit the ADNI4 Study website.